Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.16 USD | -1.19% | +5.85% | +18.52% |
02/05 | Aldeyra Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
25/04 | Transcript : Aldeyra Therapeutics, Inc. - Special Call |
Business Summary
Number of employees: 10
Managers
Managers | Title | Age | Since |
---|---|---|---|
Todd Brady
CEO | Chief Executive Officer | 52 | 01/05/01 |
Bruce Greenberg
DFI | Director of Finance/CFO | 56 | 01/19/01 |
Caitlin Pazzano
PRN | Corporate Officer/Principal | - | 01/22/01 |
Kelly Mizer
PRN | Corporate Officer/Principal | - | 01/21/01 |
Stephen Machatha
PRN | Corporate Officer/Principal | 47 | 01/21/01 |
James A. Gow
PRN | Corporate Officer/Principal | - | 12/20/12 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Phillips
BRD | Director/Board Member | 58 | 01/09/01 |
Martin Joyce
BRD | Director/Board Member | 70 | 01/13/01 |
Ben Bronstein
BRD | Director/Board Member | 74 | 01/10/01 |
Todd Brady
CEO | Chief Executive Officer | 52 | 01/05/01 |
Neal Walker
BRD | Director/Board Member | 54 | 01/13/01 |
Richard Douglas
CHM | Chairman | 71 | 13/16/13 |
Director/Board Member | 65 | 13/20/13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 59,414,489 | 48,953,902 ( 82.39 %) | 0 | 82.39 % |
Company contact information
Aldeyra Therapeutics, Inc.
131 Hartwell Avenue Suite 320
02421, Lexington
+781 761 4904
http://www.aldeyra.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.52% | 247M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |
- Stock Market
- Equities
- ALDX Stock
- Company Aldeyra Therapeutics, Inc.